Serum Institute resumes COVID-19 vaccine exports
PTI, Nov 26, 2021, 6:29 PM IST
Serum Institute of India — the world’s largest vaccine maker — on Friday said it has resumed exports of Covishield vaccine to low- and middle-income countries with the first batch of consignment leaving its Pune facility.
The vaccine maker has cumulatively produced 1.25 billion doses so far, a company statement said.
”The first batches of its COVISHIELD COVID-19 vaccine left the SII manufacturing facility in Pune earlier today, for distribution to low- and middle-income countries via the COVAX mechanism,” it said. ”SII’s supply of doses via COVAX is expected to increase substantially into Quarter 1 2022,” it added.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Three killed as Coast Guard helicopter crashes in Gujarat’s Porbandar
Theatre stampede case: Actor Allu Arjun appears before police, ‘cancels’ proposed visit to hospital
Brides decamps with cash, jewellery mid-wedding in UP’s Gorakhpur
Govt launches 2 special categories visas for international students
Unmarried couples no longer welcome, OYO changes check-in rules
MUST WATCH
Latest Additions
Gavaskar upset after not being invited to present BGT with Border
Karnataka govt likely finding excuses to halt guarantee schemes: Union Minister Kumaraswamy
Three killed as Coast Guard helicopter crashes in Gujarat’s Porbandar
Theatre stampede case: Actor Allu Arjun appears before police, ‘cancels’ proposed visit to hospital
Brides decamps with cash, jewellery mid-wedding in UP’s Gorakhpur
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.